Log In
Print
BCIQ
Print
Print this Print this
 

Relaxin (formerly ConXn)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionRecombinant human relaxin-H2
Molecular Target Relaxin-insulin-like family peptide receptor 2 (RXFP2) (LGR8) (GPR106)
Mechanism of ActionRelaxin receptor agonist
Latest Stage of DevelopmentPhase II
IndicationHeart failure
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today